Bioinformatics and Systems Medicine Laboratory
General information | Expression | Regulation | Mutation | Interaction

Basic Information

Gene ID

9021

Name

SOCS3

Synonymous

ATOD4|CIS3|Cish3|SOCS-3|SSI-3|SSI3;suppressor of cytokine signaling 3;SOCS3;suppressor of cytokine signaling 3

Definition

CIS-3|STAT-induced STAT inhibitor 3|cytokine-induced SH2 protein 3|cytokine-inducible SH2 protein 3

Position

17q25.3

Gene Type

protein-coding

Gene Regulation:

Transcription Factors
Post Transcriptional Modification From dbPTM
Methylation Profile From DiseaseMeth database

Transcription Factors

   | Top |

Regulation From TransFac database

Jak1(m){pY} + SOCS-3(h) <==> Jak1(m){pY}:SOCS-3(h) (binding)
IL-2Rbeta(h){pY}:Jak1(h){pY} + SOCS-3(h) <==> IL-2Rbeta(h){pY}:Jak1(h){pY}:SOCS-3(h) (binding)
EpoR(h){pY401} + SOCS-3(h) <==> EpoR(h){pY401}:SOCS-3(h) (binding)
EpoR(h){pY429}{pY431} + SOCS-3(h) <==> EpoR(h){pY429}{pY431}:SOCS-3(h) (binding)
SOCS-3(h) + Jak2(m) <==> SOCS-3(h):Jak2(m) (binding)
SOCS-3(h) + EpoR(m){pY401} <==> SOCS-3(h):EpoR(m){pY401} (binding)
SOCS-3(h) + bcl10(h) <==> SOCS-3(h):bcl10(h) (binding)
SOCS-3(h) + Jak3(h) <==> SOCS-3(h):Jak3(h) (binding)
SOCS-3(h) --/ IFNgamma(h) (decrease of abundance)
lepr-B(m){pY985} + SOCS-3(h) <==> lepr-B(m){pY985}:SOCS-3(h) (binding)
SOCS-3(h) + Pin1(h) <==> SOCS-3(h):Pin1(h) (binding)
SOCS3(h) --> SOCS-3(h) (expression).
IL-2(m.s.) --> SOCS-3(h) (increase of abundance)
prolactin(h) --/ SOCS-3(h) (decrease of abundance)
IFNgamma(m.s.) --> SOCS-3(h) (increase of abundance)
IGF-1R(m.s.) + SOCS-3(h) <==> IGF-1R(m.s.):SOCS-3(h) (binding)
SOCS-3(h) + IGF-1R(h){pY} <==> SOCS-3(h):IGF-1R(h){pY} (binding)
SOCS-3(h) + ATP --> SOCS-3(h){pY} + ADP (phosphorylation)
SOCS-3(h) + InsR(m.s.) <==> SOCS-3(h):InsR(m.s.) (binding)
SOCS-3(h) + IGF-1R(m.s.){pY} <==> SOCS-3(h):IGF-1R(m.s.){pY} (binding)
IL-12Rbeta2(h){pY800} + SOCS-3(h) <==> IL-12Rbeta2(h){pY800}:SOCS-3(h) (binding)
SOCS-3(h) --> STAT5B(m){pY} (decrease of phosphorylation)
SOCS-3(h) --> STAT3(m){p} (decrease of phosphorylation)
SOCS-3(h) + SOCS-2(m.s.) <==> SOCS-3(h):SOCS-2(m.s.) (binding)
SOCS-3(h) --> STAT3(h){pY705} (decrease of phosphorylation)
SOCS-3(h) + FAK1(h){pY397} <==> SOCS-3(h):FAK1(h){pY397} (binding)
SOCS-3(h) + n ubiquitin(h) --> SOCS-3(h){ub(n)} (ubiquitination)
elongin B(h) + SOCS-3(h) <==> elongin B(h):SOCS-3(h) (binding)
ErbB2(h){pY1222} + SOCS-3(h) <==> ErbB2(h){pY1222}:SOCS-3(h) (binding)
SHP-2(mo) + SOCS-3(h) <==> SHP-2(mo):SOCS-3(h) (binding)
SOCS-3(h) --> rhodopsin(m) (increase of abundance)
SOCS-3(h) --> STAT3(m){pY705} (decrease of phosphorylation)
SOCS-3(h) + ASK1(m.s.) <==> SOCS-3(h):ASK1(m.s.) (binding)
SOCS3(h) --> SOCS-3(h) (expression).
elongin B(m.s.) --/ SOCS-3(h) (decrease of abundance)
elongin C(m.s.) --/ SOCS-3(h) (decrease of abundance)
LPS --> SOCS-3(h) (increase of abundance)

Post Transcriptional Modification From dbPTM

   | Top |

Location (AA)

PTM type

Literature

Database

204Phosphotyrosine (JAK2)12783885Phospho.ELM 6.0
221Phosphotyrosine (JAK2)12783885;15173187Phospho.ELM 6.0

Methylation Profile From DiseaseMeth database

   | Top |

Chromosome

Location

Source

chr17

Promoter: 73867253 - 73869253Agilent_014791

chr17

Promoter: 73867253 - 73869253GSE27584

chr17

Promoter: 73867253 - 73869253Agilent_014791_44K

chr17

Promoter: 73867253 - 73869253PMID:16007195

chr17

Promoter: 73867253 - 73869253PMID:17241887

chr17

Promoter: 73867253 - 73869253PMID:17376806

chr17

Promoter: 73867253 - 73869253PMID:16644104

chr17

Promoter: 73867253 - 73869253PMID:16007169


Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston Rights Reserved
Site Policies | State of Texas